XML 128 R5.htm IDEA: XBRL DOCUMENT v3.25.3
Condensed Consolidated Statements of Changes in Mezzanine Equity and Stockholders’ Deficit (Unaudited) - USD ($)
$ in Thousands
Mezzanine Equity
Preferred Stock
Series A
Common Stock
Class A
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Balance at Dec. 31, 2022   $ 1   $ 189,904 $ (225,985) $ (115) $ (36,195)
Balance (in Shares) at Dec. 31, 2022   10,122,581          
Dividends on the Series A Preferred Stock     (1,349) (1,349)
Stock-based compensation     1,575 1,575
Return of the subscription proceeds for the additional Series A Preferred Stock     (2,000) (2,000)
Deemed capital contribution from related party (Note 10)     18,702 18,702
Foreign currency translation adjustment     (3) (3)
Conversion of Convertible Notes into Class A Common Stock in connection with Merger (Note 3)   $ 1   27,493 27,494
Conversion of Convertible Notes into Class A Common Stock in connection with Merger (Note 3) (in Shares)   4,874,707          
Conversion of Envoy Bridge Note into Series A Preferred Stock in connection with Merger (Note 3)     10,982 10,982
Conversion of Envoy Bridge Note into Series A Preferred Stock in connection with Merger (Note 3) (in Shares)   1,000,000          
Preferred stock subscriptions (Note 3)     2,000 2,000
Net exercise of warrants (related party) (Note 10)    
Net exercise of warrants (related party) (Note 10) (in Shares)   2,702          
Merger, net of redemptions and transaction costs (Note 3)     (1,785) (1,785)
Merger, net of redemptions and transaction costs (Note 3) (in Shares)   2,500,000 3,115,874          
Meteora forward purchase agreement shares (Note 3)     (1,384) (1,384)
Meteora forward purchase agreement shares (Note 3) (in Shares)   434,118          
Issuance of Series A Preferred stock to PIPE Investors (Note 3)     10,000 10,000
Issuance of Series A Preferred stock to PIPE Investors (Note 3) (in Shares)   1,000,000          
Issuance of Common Stock     109 109
Issuance of Common Stock (in Shares)   50,000          
Net loss     (29,922) (29,922)
Balance at Dec. 31, 2023 $ 2   255,596 (257,256) (118) (1,776)
Balance (in Shares) at Dec. 31, 2023   4,500,000 18,599,982          
Dividends on the Series A Preferred Stock   (1,365) (1,365)
Issuance of Common Stock through forward purchase agreement   1,683 1,683
Stock-based compensation   123 123
Issuance of warrants associated with the Term Loans   179 179
Foreign currency translation adjustment   (1) (1)
Net loss   (6,270) (6,270)
Balance at Mar. 31, 2024 $ 2   257,581 (264,891) (119) (7,427)
Balance (in Shares) at Mar. 31, 2024   4,500,000 18,599,982          
Balance at Dec. 31, 2023 $ 2   255,596 (257,256) (118) (1,776)
Balance (in Shares) at Dec. 31, 2023   4,500,000 18,599,982          
Foreign currency translation adjustment               (3)
Net loss               (16,177)
Balance at Sep. 30, 2024 $ 2   259,119 (277,543) (121) (18,543)
Balance (in Shares) at Sep. 30, 2024   4,500,000 18,730,982          
Balance at Dec. 31, 2023 $ 2   255,596 (257,256) (118) (1,776)
Balance (in Shares) at Dec. 31, 2023   4,500,000 18,599,982          
Dividends on the Series A Preferred Stock     (5,521) (5,521)
Sale of Class A Common Stock through forward purchase agreement     1,683 1,683
Exercise of shortfall warrants     1,815 1,815
Exercise of shortfall warrants (in Shares)   664,883          
Extinguishment of excess warrant liability upon exercise of warrants associated with the forward purchase agreement     96 96
Modification of forward purchase agreement     (94) (94)
Issuance of Common Stock for services (in Shares)       425,606        
Issuance of Common Stock under employee stock purchase plan     63 63
Issuance of Common Stock under employee stock purchase plan (in Shares)   32,758          
Waiver of accrued dividends associated with Sponsor Support Agreement     3,733 3,733
Induced conversion of Series A Preferred Stock into Class A Common Stock     1,162 (1,162)
Induced conversion of Series A Preferred Stock into Class A Common Stock (in Shares)   (373,333) 1,028,986          
Waiver of restriction and vesting requirement of Common Stock    
Waiver of restriction and vesting requirement of Common Stock (in Shares)   1,000,000          
Stock-based compensation     562 562
Issuance of warrants associated with the Term Loans     1,397 1,397
Foreign currency translation adjustment     (5) (5)
Issuance of Series A Preferred stock to PIPE Investors (Note 3) (in Shares)   1,000,000            
Net loss     (20,795) (20,795)
Balance at Dec. 31, 2024 $ 2   266,013 (284,734) (123) (18,842)
Balance (in Shares) at Dec. 31, 2024   4,126,667 21,326,609          
Balance at Mar. 31, 2024 $ 2   257,581 (264,891) (119) (7,427)
Balance (in Shares) at Mar. 31, 2024   4,500,000 18,599,982          
Dividends on the Series A Preferred Stock   (1,365) (1,365)
Stock-based compensation   142 142
Issuance of warrants associated with the Term Loans   197 197
Foreign currency translation adjustment   (1) (1)
Net loss   (3,947) (3,947)
Balance at Jun. 30, 2024 $ 2   257,920 (270,203) (120) (12,401)
Balance (in Shares) at Jun. 30, 2024   4,500,000 18,599,982          
Dividends on the Series A Preferred Stock   (1,380) (1,380)
Exercise of shortfall warrants   450 450
Exercise of shortfall warrants (in Shares)     131,000          
Modification of forward purchase agreement warrant   (94) (94)
Stock-based compensation   144 144
Issuance of warrants associated with the Term Loans   699 699
Foreign currency translation adjustment   (1) (1)
Net loss   (5,960) (5,960)
Balance at Sep. 30, 2024 $ 2   259,119 (277,543) (121) (18,543)
Balance (in Shares) at Sep. 30, 2024   4,500,000 18,730,982          
Balance at Dec. 31, 2024 $ 2   266,013 (284,734) (123) (18,842)
Balance (in Shares) at Dec. 31, 2024   4,126,667 21,326,609          
Dividends on the Series A Preferred Stock   (1,238) (1,238)
Stock-based compensation   160 160
Issuance of warrants associated with the Term Loans   688 688
Foreign currency translation adjustment   6 6
Net loss   (4,998) (4,998)
Balance at Mar. 31, 2025 $ 2   266,861 (290,970) (117) (24,224)
Balance (in Shares) at Mar. 31, 2025   4,126,667 21,326,609          
Balance at Dec. 31, 2024 $ 2   266,013 (284,734) (123) (18,842)
Balance (in Shares) at Dec. 31, 2024   4,126,667 21,326,609          
Foreign currency translation adjustment               3
Net loss               (17,170)
Balance at Sep. 30, 2025 $ 130 $ 2   298,116 (305,659) (120) (7,661)
Balance (in Shares) at Sep. 30, 2025 143,130 4,126,667 23,809,975          
Balance at Mar. 31, 2025 $ 2   266,861 (290,970) (117) (24,224)
Balance (in Shares) at Mar. 31, 2025   4,126,667 21,326,609          
Dividends on the Series A Preferred Stock   (1,252) (1,252)
Issuance of Common Stock from ATM offering   204 204
Issuance of Common Stock from ATM offering (in Shares)     134,771          
Issuance of Common Stock under employee stock purchase plan   77 77
Issuance of Common Stock under employee stock purchase plan (in Shares)     59,552          
Stock-based compensation   146 146
Issuance of warrants associated with the Term Loans   882 882
Foreign currency translation adjustment   (2) (2)
Net loss   (5,690) (5,690)
Balance at Jun. 30, 2025 $ 2   268,170 (297,912) (119) (29,859)
Balance (in Shares) at Jun. 30, 2025   4,126,667 21,520,932          
Dividends on the Series A Preferred Stock   (1,265) (1,265)
Issuance of Common Stock from ATM offering   210 210
Issuance of Common Stock from ATM offering (in Shares)     165,971          
Modification of forward purchase agreement warrant   (62) (62)
Exercise of forward purchase agreement warrant   158 158
Exercise of forward purchase agreement warrant (in Shares)     105,000          
Issuance of Common Stock from registered direct offering  
Issuance of Common Stock from registered direct offering (in Shares)     1,908,402          
Issuance of Placement Agent Warrants $ 130  
Issuance of Placement Agent Warrants (in Shares) 143,130              
Issuance of Common Stock for services   134 134
Issuance of Common Stock for services (in Shares)     109,670          
Modification of Term Loan Warrants   1,455 1,455
Extinguishment of Term Loans   27,879 27,879
Stock-based compensation   172 172
Foreign currency translation adjustment   (1) (1)
Net loss   (6,482) (6,482)
Balance at Sep. 30, 2025 $ 130 $ 2   $ 298,116 $ (305,659) $ (120) $ (7,661)
Balance (in Shares) at Sep. 30, 2025 143,130 4,126,667 23,809,975